Preparation and In Vivo Evaluation of Rosmarinic Acid-Loaded Transethosomes After Percutaneous Application on a Psoriasis Animal Model

• Published in: AAPS PharmSciTech Vol. 22; no. 3; p. 103
• Main Authors: Rodríguez-Luna, Azahara, Talero, Elena, Ávila-Román, Javier, Romero, Ana María Fernández, Rabasco, Antonio M., Motilva, Virginia, González-Rodríguez, María Luisa
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 12.03.2021
• Subjects: Administration, Cutaneous; Animals; Biochemistry; Biomedical and Life Sciences; Biomedicine; Biotechnology; Cinnamates - administration & dosage; Cinnamates - therapeutic use; Depsides - administration & dosage; Depsides - therapeutic use; Dexamethasone - administration & dosage; Dexamethasone - therapeutic use; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Female; Gels; Mice; Mice, Inbred BALB C; Pharmacology/Toxicology; Pharmacy; Psoriasis - drug therapy; Research Article; Rosmarinic Acid; Viscosity; rosmarinic acid; caffeic acid; transethosomes; psoriasis; stability
• ISSN: 1530-9932; 1530-9932
• DOI: 10.1208/s12249-021-01966-3

The topical use of rosmarinic acid (RA) in skin inflammatory pathologies is restricted due to its poor water solubility, poor permeability, and chemical instability. In this study, RA-loaded transethosomes-in-Carbopol ® formulations have been developed to evaluate its anti-inflammatory activity on imiquimod-induced psoriasis-like skin inflammation in mice. In vitro release profiles demonstrated sustained behavior due to the retentive action of gel and the entrapment of RA into the vesicles. However, the low viscosity of the combined formulation increased the drug release rate. Animal evaluation of anti-inflammatory activity demonstrated that transethosomes-in-gel containing dexamethasone (Dex-TE-Gel), as positive control, showed effect in all the pro-inflammatory parameters evaluated, evidencing that these drug-loaded nanocarriers have been effectively reached the site of action. In addition, transethosomes-in-gel containing RA (RA-TE-Gel) formulations produced a great reduction in the punch edema ( P < 0.001) and in TNF-α and IL-6 ( P < 0.05). However, non-significant differences were obtained for IL-1β, IL17, and MPO. Despite the protecting effect of Carbopol ® and transethosomes on oxidation index and antioxidant activity of RA over the 7 days of treatment, however, a degradation process of this antioxidant to caffeic acid may be the cause of these in vivo results. We have also checked that the pH existing into the intercellular space of damaged cells (pH 6.8) may be affecting. Therefore, our results suggest that RA-TE-Gel could act as an effective RA formulation for skin delivery; further studies will help to understand the loss of activity at the cellular level.